Glycemic Control
Analytical reference materials for studying glucose-stimulated insulin secretion, insulin sensitivity, and beta-cell signaling in vitro.
For Research Use Only
This brief describes analytical reference materials supplied by R3TA LLC for in-vitro laboratory research. It is not a protocol and contains no dosing, administration, or therapeutic guidance. Not for human or animal consumption.
GLP-3 has been reported to improve markers of glycemic control through combined activation of GLP-1, GIP, and glucagon receptors in research settings.
R3TA reference materials support in-vitro assays of glucose-stimulated insulin secretion, beta-cell viability, and insulin-receptor signaling.
These materials are not intended for therapeutic or diagnostic use. For Research Purpose Only.
Representative in-vitro endpoints
- —Glucose-stimulated insulin secretion in INS-1 or primary islet cultures
- —cAMP response in GLP-1R / GIPR expressing cell lines
- —Insulin-receptor phosphorylation and downstream signaling panels
- —Beta-cell proliferation and apoptosis endpoints
Handling & storage
- —Store lyophilized at −20 °C, desiccated
- —Reconstitute with sterile diluent under aseptic technique
- —Keep reconstituted aliquots at 2–8 °C for short-term use only
- —Discard per institutional chemical waste procedures
Analytical documentation
- —Per-lot RP-HPLC purity report
- —Mass confirmation by ESI-MS
- —Peptide content by amino acid analysis on request